9:15 AM
Aug 16, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Lung cancer

Cell culture studies suggest inhibiting IKK or its scaffold protein NEMO in combination with inhibition of MC-1 could help treat STK11-deficient lung cancer. In a human STK11-deficient lung cancer cell line, the MC-1 inhibitor phenformin plus...

Read the full 168 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >